Cited by 111Blood Pressure and Hypertension StudiesReproductive Health and ContraceptionHormonal Regulation and Hypertension

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Oral contraceptives and hypertension.

Open access

Woods, J W·1988·Hypertension

DOI 10.1161/01.hyp.11.3_pt_2.ii11

Open this paper in CoChat — free account Open PDF

Abstract

Oral contraceptives result in a mild elevation of blood pressure in most women and overt hypertension in about 5%. Both estrogen and progestogen are responsible for the blood pressure effect, but the mechanism is as yet unknown. The risk of cardiovascular complications is found primarily in women over 35 years of age and in those who smoke. Preparations with an estrogen content of 30 g and a progestogen content of 1 mg or less appear to be safe.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.11.3_pt_2.ii11

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Oral Contraceptives and Cardiovascular Disease
Stadel, B. V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051104 · Cited by 494
Oral Contraceptives: Renin, Aldosterone, and High Blood Pressure
Laragh, J. H. (1967) · JAMA · doi:10.1001/jama.1967.03130120026007 · Cited by 229
Red-Cell Lithium-Sodium Countertransport and Renal Lithium Clearance in Hypertension
Weder, A. B. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601233140402 · Cited by 182
Blood Pressure in Women Taking Oral Contraceptives
Weir, R. J., Briggs, E., Mack, A., Naismith, L., Taylor, L., & Wilson, E. (1974) · BMJ · doi:10.1136/bmj.1.5907.533 · Cited by 164
ORAL CONTRACEPTIVES AND HYPERTENSION
Woods, J. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90690-3 · Cited by 131
Self-citation
THE EFFECT OF THE ADMINISTRATION OF ESTROGENS ON THE RENIN-SUBSTRATE (HYPERTENSINOGEN) CONTENT OF RAT PLASMA
Helmer, O. M., Griffith, R. S., Sanders, R. M., & Tilden, J. H. (1952) · Endocrinology · doi:10.1210/endo-51-5-421 · Cited by 122
A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release
Saruta, T. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.126.4.621 · Cited by 120
FURTHER ANALYSES OF MORTALITY IN ORAL CONTRACEPTIVE USERS *1Royal College of General Practitioners' Oral Contraception Study
(1981) · The Lancet · doi:10.1016/s0140-6736(81)92872-5 · Cited by 119
The effect of intrauterine devices, oral contraceptives, estrogens, and progestogens on blood pressure
Spellacy, W. N., & Birk, S. A. (1972) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(72)90811-3 · Cited by 95
Blood pressure and contraceptive use
Khaw, K., & Peart, W. S. (1982) · BMJ · doi:10.1136/bmj.285.6339.403 · Cited by 84

Flagged first, then by citations

Show all 21 references

1 of the 21 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

Saruta T, Saade GA, Kaplan NM. A possible mechanism for hypertension induced by oral contraceptives. Arch Intern Med 1970; 126:621-626
Report of the Royal College of General Practitioners. Hyper- tension. In: Oral contraceptives and health. London: Pitmann, 8. Vessey MP, McPherson K, Johnson B. Mortality among wom- en participating in the Oxford University Family Planning As- sociation Contraceptive Study. Lancet 1974;2:731-733
Stem MP, Brown BW Jr, Haskell WL, Farquhar JW, Wehrle CL, Woods PDS. Cardiovascular risk and use of estrogens or estrogen-progestogen combinations. Stanford Three-Commu- nity Study. JAMA 1976;235:811-815
Royal College of General Practitioners Oral Contraceptive Study. Effect on hypertension and benign breast disease of progestogen component in combined oral contraceptives. Lan- cet 1977; 1:624
Fowler WL Jr, Johnson JA, Kurz KD, Payne CG. Renin- angiotensin mechanisms in oral contraceptive hypertension in conscious rats. Am J Physiol 1985;248:H695-H699

Sorted by citations

2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
2007 Guidelines for the management of arterial hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cifkova, R., Fagard, R., Germano, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,410
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
VI Diretrizes Brasileiras de Hipertensão
Nobre, F., Tavares, A., Brandão, A. A., Sanjuliani, A. F., Nogueira, A. D. R., Machado, C. A., Figueiredo, C. E. P. D., Negrão, C. E., Amodeo, C., Rodrigues, C. I. S., et al. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001700001 · Cited by 618
Prospective Study of Oral Contraceptives and Hypertension Among Women in the United States
Chasan-Taber, L., Willett, W. C., Manson, J. E., Spiegelman, D., Hunter, D. J., Curhan, G., Colditz, G. A., & Stampfer, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.3.483 · Cited by 328
Hypertension in Women
August, P., & Oparil, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5724 · Cited by 198
Estrogen and hypertension
Ashraf, M. S., & Vongpatanasin, W. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0080-1 · Cited by 162
Estrogen Supplementation Decreases Norepinephrine-Induced Vasoconstriction and Total Body Norepinephrine Spillover in Perimenopausal Women
Sudhir, K., Esler, M., Jennings, G., & Komesaroff, P. A. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1538 · Cited by 152
Hypertension in Women of Reproductive Age in the United States: NHANES 1999-2008
Bateman, B. T., Shaw, K. M., Kuklina, E. V., Callaghan, W. M., Seely, E. W., & Hernández–Dı́az, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036171 · Cited by 139
Refractory Hypertension
Desforges, J. F., Setaro, J. F., & Black, H. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208203270808 · Cited by 130
Effect of oral contraceptives on the renin angiotensin system and renal function
Kang, A. K., Duncan, J. A., Cattran, D. C., Floras, J. S., Lai, V., Scholey, J. W., & Miller, J. A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.3.r807 · Cited by 103
Contraception in Women With Congenital Heart Disease
Vigl, M., Kaemmerer, M., Seifert‐Klauss, V., Niggemeyer, E., Nagdyman, N., Trigas, V., Bauer, U. M. M., Schneider, K.-T. M., Berger, F. F., Hess, J., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.060 · Cited by 97
Oral Contraceptive Pills and Hypertension: A Review of Current Evidence and Recommendations
Cameron, N. A., Blyler, C. A., & Bello, N. A. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20018 · Cited by 97
Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007
(ESH), G. D. T. P. E. T. D. L. H. A. D. L. S. E. D. H., & de Cardiología, D. L. S. E. (2007) · Revista Española de Cardiología · doi:10.1157/13109650 · Cited by 79
Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women
Harvey, R. E., Hart, E. C., Charkoudian, N., Curry, T. B., Carter, J. R., Fu, Q., Minson, C. T., Joyner, M. J., & Barnes, J. N. (2015) · HYPERTENSION · doi:10.1161/hypertensionaha.115.05179 · Cited by 76
High blood pressure. A side effect of drugs, poisons, and food
Grossman, E. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.450 · Cited by 70
Renal Characteristics and Effect of Angiotensin Suppression in Oral Contraceptive Users
Ribstein, J., Halimi, J., du Cailar, G., & Mimran, A. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.90 · Cited by 68
Hypertension in Women: Current Understanding of Gender Differences
Hayes, S. N., & Taler, S. J. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63649-5 · Cited by 68
Guías de práctica clínica de la Sociedad Española de Cardiología en hipertensión arterial
Romero, F. L., Alonso, V. B., Arcos, F. S., Peralta, L. J. P., Fernández, J. M. C., Abadal, L. T., Padial, L. R., & González‐Juanatey, J. R. (2000) · Revista Española de Cardiología · doi:10.1016/s0300-8932(00)75065-2 · Cited by 65
Ambulatory blood pressure in mild hypertensive women taking oral contraceptives a case-control study
Narkiewicz, K., ROCCOGRANIERO, G., D'Este, D., Mattarei, M., Zonzin, P., & Palatini, P. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)96212-3 · Cited by 63
Menopause induced by oophorectomy reveals a role of ovarian estrogen on the maintenance of pressure homeostasis
Mercuro, G. G., Zoncu, S., Saiu, F., Mascia, M., Melis, G. B., & Rosano, G. M. C. (2003) · Maturitas · doi:10.1016/s0378-5122(03)00252-4 · Cited by 61
Infertility, fertility treatment, and risk of hypertension
Farland, L. V., Grodstein, F., Srouji, S. S., Forman, J. P., Rich-Edwards, J., Chavarro, J. E., & Missmer, S. A. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.04.043 · Cited by 55
Low-Dose Estrogen Supplementation Improves Vascular Function in Hypogonadal Men
Komesaroff, P. A., Fullerton, M. J., Esler, M., Dart, A. M., Jennings, G., & Sudhir, K. (2001) · Hypertension · doi:10.1161/hy1101.095006 · Cited by 54
Effects of hormonal replacement therapy in postmenopausal hypertensive patients
Affinito, P., Palomba, S., Bonifacio, M., Fontana, D., Izzo, R., Trimarco, B., & Nappi, C. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00196-7 · Cited by 52
Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk
Godsland, I. F., & Crook, D. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)05015-5 · Cited by 51
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate
Thobari, J. A., Gansevoort, R. T., Visser, S. T., de Jong, P. E., den Berg, L. T. W. D. J., & the PREVEND study group (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02747.x · Cited by 48
Drug-induced arterial hypertension – a frequently ignored cause of secondary hypertension: a review
Diaconu, C. C., Dediu, G. N., & Iancu, M. A. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2017.1421445 · Cited by 46
Occlusive Vascular Diseases in Oral Contraceptive Users
Godsland, I. F., Winkler, U. H., Lidegaard, Ø., & Crook, D. (2000) · Drugs · doi:10.2165/00003495-200060040-00003 · Cited by 46
Gender Differences in Hypertension and Kidney Disease
Reyes, D., Lew, S. Q., & Kimmel, P. L. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.11.010 · Cited by 44
The hypertensive potential of estrogen: An untold story
Fardoun, M., Dehaini, H., Shaito, A. A., Mesmar, J. E., EL‐Yazbi, A. F., Badran, A., Beydoun, E., & Eid, A. H. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2019.106600 · Cited by 46
Drug-Induced Cardiovascular Disorders
Murphy, C. A., & Dargie, H. J. (2007) · Drug Safety · doi:10.2165/00002018-200730090-00005 · Cited by 39
Women Health in Saudi Arabia: A review of non-communicable diseases and their risk factors
Alquaiz, A. M., Siddiqui, A., Qureshi, R. H., Fouda, M. A., Almuneef, M. A., Habib, F., & Turkistani, I. Z. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.302.4378 · Cited by 39
2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European
Mancia, G., Dominiczak, A. F., Fagard, R. H., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Schmieder, R. E., Vahanian, A. S., Camm, A. J., Dean, V., et al. (2007) · Cited by 38
Combined Oral Contraceptive Pill-Induced Hypertension and Hypertensive Disorders of Pregnancy: Shared Mechanisms and Clinical Similarities
Gunaratne, M. D. S. K., Thorsteinsdottir, B., & Garovic, V. D. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01147-4 · Cited by 35
The effect of oral contraceptive agents on the basal metabolic rate of young women
Diffey, B., Piers, L. S., Soares, M. J., & O’Dea, K. (1997) · British Journal Of Nutrition · doi:10.1079/bjn19970084 · Cited by 34
Sex differences in arterial wave reflection and the role of exogenous and endogenous sex hormones: results of the Berlin Aging Study II
Seeland, U., Demuth, I., Regitz‐Zagrosek, V., Steinhagen‐Thiessen, E., & König, M. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002386 · Cited by 32
Chronic estradiol-17β exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol
Subramanian, M., Balasubramanian, P., Garver, H. S., Northcott, C. A., Zhao, H., Haywood, J. R., Fink, G. D., MohanKumar, S. M. J., & MohanKumar, P. S. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00020.2011 · Cited by 30
The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review
Özcan, Ö., den Elzen, W. P. J., Hillebrand, J. J., den Heijer, M., van Loendersloot, L. L., Fischer, J., Hamer, H. M., de Jonge, R., & Heijboer, A. C. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0384 · Cited by 35
Sex-Specific Disparities in Risk Factors for Coronary Heart Disease
Rosen, S. E., Henry, S. A., Bond, R. M., Pearte, C. A., & Mieres, J. H. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0523-8 · Cited by 26
Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats
Morimoto, K., Kurahashi, Y., Shintani‐Ishida, K., Kawamura, N., Miyashita, M., Uji, M., Tan, N., & Yoshida, K. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00341.2004 · Cited by 26
Hypertension in Women
August, P. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.07.002 · Cited by 25
Dyslipidaemia, combined oral contraceptives use and their interaction on the risk of hypertension in Chinese women
Wei, W., Li, Y., Chen, F., Chen, C., Sun, T., Sun, Z. Y., Wu, Y., Zhou, J., & Ba, L. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.67 · Cited by 23
Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
Afshari, M., Alizadeh‐Navaei, R., & Moosazadeh, M. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01376-4 · Cited by 22
Ovarian angiotensin-converting enzyme activity in humans: relationship to estradiol, age, and uterine pathology
Erman, A., Chen-Gal, B., van Dijk, D. J., Sulkes, J., Kaplan, B., Boner, G., & Neri, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772583 · Cited by 21
Resistant Hypertension Updated Guidelines
Chernova, I., & Krishnan, N. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1209-6 · Cited by 21
Use of oral contraceptives and serum beta-carotene
Berg‐Beckhoff, G., Kohlmeier, L., & Brenner, H. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600384 · Cited by 20
Secondary Hypertension due to Drugs and Toxins
Gyamlani, G. G., & Geraci, S. A. (2007) · Southern Medical Journal · doi:10.1097/smj.0b013e318063c3e8 · Cited by 18
Hypertension in Women: A South-Asian Perspective
Farrukh, F., Abbasi, A., Jawed, M., Almas, A., Jafar, T. H., Virani, S. S., & Samad, Z. Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.880374 · Cited by 24
Chronic estradiol exposure – harmful effects on behavior, cardiovascular and reproductive functions
MohanKumar, S. M. J., Balasubramanian, P., Subramanian, M., & MohanKumar, P. S. (2018) · Reproduction · doi:10.1530/rep-18-0116 · Cited by 18
EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes
Zhang, Z., Tremblay, J., Raelson, J., Sofer, T., Du, L., Fang, Q., Argos, M., Marois-Blanchet, F.-C., Wang, Y., Yan, L., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000001948 · Cited by 17
Secondary Hypertension, Issues in Diagnosis and Treatment
Pullalarevu, R., Akbar, G., & Teehan, G. S. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.08.001 · Cited by 15
Case Reports and Medical Progress
Simpson, R. J., & Griggs, T. R. (1985) · Perspectives in biology and medicine · doi:10.1353/pbm.1985.0005 · Cited by 15
Endocrine Causes of Hypertension in Children
Rodd, C. J., & Sockalosky, J. J. (1993) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38487-5 · Cited by 15
Oral hormonal contraceptives and cardiovascular risks in females
Bhullar, S. K., Rabinovich-Nikitin, I., & Kirshenbaum, L. A. (2024) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0041 · Cited by 15
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives
Leo, V. D., Marca, A. L., Morgante, G., Lucani, B., Nami, R., Ciotta, L., Cianci, A., & Petraglia, F. (2001) · Contraception · doi:10.1016/s0010-7824(01)00237-2 · Cited by 14
"Gender specific medicine": a focus on gender-differences in hypertension.
Bălan, H., & Popescu, L. (2014) · PubMed · Cited by 14
Nonemergent Hypertension
Thach, A. M., & Schultz, P. (1995) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(20)30598-8 · Cited by 14
Hormonal contraception and risk for cognitive impairment or Alzheimer's disease and related dementias in young women: a scoping review of the evidence
Gregory, S., Booi, L., Jenkins, N. D., Bridgeman, K., Terrera, G. M., & Farina, F. R. (2023) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2023.1289096 · Cited by 13
Angiotensin-converting enzyme and angiotensinogen gene polymorphisms are non-randomly distributed in oral contraceptive-induced hypertension.
Mulatero, P., Rabbia, F., di Cella, S. M., Schiavone, D., Plazzotta, C., Pascoe, L., & Veglio, F. (2001) · Journal of Hypertension · doi:10.1097/00004872-200104000-00008 · Cited by 13
Haemodynamic and Metabolic Effects of Short Term Administration of Synthetic Sex Steroids in Humans
Whitworth, J. A., Scoggins, B. A., Andrews, J., Williamson, P. M., & Brown, M. A. (1992) · Clinical and Experimental Hypertension · doi:10.3109/10641969209036226 · Cited by 13
Chronic estrogen exposure affects gene expression in the rostral ventrolateral medulla of young and aging rats: Possible role in hypertension
Subramanian, M., Hahn-Townsend, C., Clark, K. A., MohanKumar, S. M. J., & MohanKumar, P. S. (2015) · Brain Research · doi:10.1016/j.brainres.2015.09.007 · Cited by 12
Immunomodulatory Potential of Diuretics
Bryniarski, P., Nazimek, K., & Marcinkiewicz, J. (2021) · Biology · doi:10.3390/biology10121315 · Cited by 12
Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women
Morgante, G., Delia, A., Musacchio, M. C., Severi, F. M., Petraglia, F., & Leo, V. D. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600850300 · Cited by 10
Plasma Concentrations of Atrial Natriuretic Factor in Normal Pregnancy and Early Puerperium
Marlettini, M. G., Cassani, A., Boschi, S., Labate, A. M. M., Crippa, S., Borghi, C., Contarini, A., Rusticali, A. G., & Orlandi, C. (1989) · Clinical and Experimental Hypertension · doi:10.3109/10641968909035359 · Cited by 10
Hypertension in women
Taler, S. J. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0006-9 · Cited by 9
Aldosterone and angiotensin II profiles in young black and white women using different hormonal contraceptives: the African-PREDICT study
van Rooyen, J. M., Poglitsch, M., Mels, C. M. C., Huisman, H. W., Gafane-Matemane, L. F., Roux, S. B., Lammertyn, L., Breet, Y., Uys, L., & Schutte, A. E. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-021-00569-6 · Cited by 8
High-calcium diet reduces blood pressure, blood volume and preserves vasorelaxation in oral contraceptive-treated female rats
Olatunji, L. A., & Soladoye, A. O. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.12.003 · Cited by 8
Genetic and nongenetic determinants of blood pressure in a Southern Brazilian sample
Robinson, W. M., Borges-Osório, M. R., Callegari-Jacques, S. M., Achutti, A., da Silveira, L. G., Klein, C. H., Costa, E. A., Rao, D. C., & Vogler, G. P. (1991) · Genetic Epidemiology · doi:10.1002/gepi.1370080106 · Cited by 8
Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature
Mir, D. I., Ardabilygazir, A., Afshariyamchlou, S., & Sachmechi, I. (2018) · Cureus · doi:10.7759/cureus.2978 · Cited by 7
Sex hormones and related compounds including hormonal contraceptives
von Eickstedt, K.-W. (1990) · Side effects of drugs annual · doi:10.1016/s0378-6080(05)80107-2 · Cited by 7
Hypertension, genotype and oral contraceptives
Mulatero, P., di Cella, S. M., di Cella, S. M., & Veglio, F. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.1.57 · Cited by 7
EFFECTS OF 17P‐OESTRADIOL ON VASCULAR RESPONSES IN THE IN SITU BLOOD‐PERFUSED MESENTERY OF WISTAR‐KYOTO RATS
Chu, Z., & Beilin, L. J. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb01216.x · Cited by 6
Sex Hormones and Their Impact on Cardiovascular Health
Jesus, S. D., Gianos, E., McNally, S. T., Scantlebury, D. C., & Rosen, S. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819369-3.00029-0 · Cited by 8
Hormone replacement therapy increases renal kallikrein excretion in healthy postmenopausal women
Farag, N. H., Mahata, M., Ziegler, M. G., O’Connor, D. T., & Mills, P. J. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02380-9 · Cited by 5
Hypertension in Women
Weyer, G. W., Dunlap, B., & Shah, S. D. (2016) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2016.01.002 · Cited by 5
Cardiovascular Risk in Postmenopausal Women: What is Known and what is Unknown
Manhem, K. (1994) · Springer eBooks · doi:10.1007/978-3-642-79077-5_2 · Cited by 5
Molekularbiologie, Klinik und Therapie steroidbedingter Hypertonien
Peters, J., Hampf, M., Peters, B., & Bernhardt, R. (1998) · Springer eBooks · doi:10.1007/978-3-642-80360-4_13 · Cited by 5
The role of the sympathetic nervous system in oestrogen‐induced hypertension in rats
Bhatt, J., & Gulati, O. D. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb11172.x · Cited by 5
Hormone Replacement Therapy and Hypertension: Relationship to the Renin-Angiotensin System
Cacciabaudo, J. M., & Sealey, J. E. (1994) · Springer eBooks · doi:10.1007/978-3-642-79077-5_6 · Cited by 4
Factores que influyen en la hipertensión arterial refractaria
de la Morena, J. S., Sien, C. C., & Urioste, L. M. R. (2002) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(02)71260-9 · Cited by 4
Cardiac and Neurologic Complications in Malignant Hypertension due to Oral Contraceptive Use
Bortolotto, L. A., Silva, H. B., & Pileggi, F. J. C. (1994) · Blood Pressure · doi:10.3109/08037059409102280 · Cited by 4
Hypertension
Waeber, B., Brunner, H.-R., Burnier, M., & Cohn, J. N. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_89 · Cited by 4
Endocrine Hypertension
Kaplan, N. M. (1995) · Endocrine Practice · doi:10.4158/ep.1.2.91 · Cited by 4
Humoral Control of the Circulation
Oparil, S., & Katholi, R. E. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-275820-1.50007-8 · Cited by 4
Estrogen and Cardiovascular Disease
Peterson, L. R. (2008) · Springer eBooks · doi:10.1007/978-0-585-33754-8_43 · Cited by 3
Hipertensão em situações especiais
Poli‐de‐Figueiredo, C. E., Tavares, A., de Freitas, E. V., Burdmann, E. A., de Oliveira, I. L. C., Magalhães, L. C., Sass, N., Bresolin, N. L., Bezerra, R., Koch, V. H. K., et al. (2010) · Brazilian Journal of Nephrology · doi:10.1590/s0101-28002010000500010 · Cited by 4
[Malignant hypertension and irreversible kidney failure associated with oral contraception pills intake].
Riera, M., Navas-Parejo, A., Gomez, M., & Cerezo, S. (2004) · PubMed · Cited by 3
Male Pseudohermaphroditism Resulting From 17α-Monooxygenase (P-450C17) Deficiency in Two Unrelated Guamanians
Jones, K. L. (1992) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1992.02160170072018 · Cited by 3
Hypertension and cardiovascular disease risk in women
Thadani, U. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199601000-00003 · Cited by 3
Effect of Combined Oral Contraceptive Pills on Renal Function Tests
Al-Jomard, S. A., & Al-Youzbaki, W. B. (2012) · Iraqi Journal of Community Medicine · Cited by 2
Hypertension in Women: Impact of Contraception, Fertility, and Hormone Treatment
Wilkie, G., Skaritanov, E., Tobin, M. J., Essa, A., Gubala, A. M., Ferraro, L., & Kovell, L. C. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00705-y · Cited by 2
"Hipertensão arterial e fatores de risco associados: estudo entre universitários da cidade de Lubango-Angola"
Simão, M. (2005) · doi:10.11606/t.22.2005.tde-13092005-105607 · Cited by 2
Hormone Therapy and Blood Pressure in Postmenopausal Women
Sumino, H., Ichikawa, S., Kasama, S., Takahashi, T., Kumakura, H., Takayama, Y., Minami, K., Kanda, T., Kurabayashi, M., & Murakami, M. (2011) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2011.04.005 · Cited by 1
A long-term study of the hematological and metabolic effects of a low-dose monophasic oral contraceptive containing gestodene
Solerte, S. B., Fioravanti, M., Spinillo, A., Berard, P., Severgnini, S., Ferrari, E., & Guaschino, S. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609049603 · Cited by 1
Gonadectomy-induced Reduction of Antihypertensive Action of Angiotensin Converting Enzyme Inhibitor and its Role of Central Renin Activity in Spontaneously Hypertensive Rats
Kumai, T. (1991) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.67.11_1231 · Cited by 1
HYPERTENSION
Zoorob, R., Arif, A. M., & Morelli, V. (2000) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(05)70165-2 · Cited by 1
Effects of oestrogen on haemodynamic and vascular reactivity - A study in animal models and humans
Brandin, L. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Causes of Resistant Hypertension
Schmieder, R. E. (2013) · Springer eBooks · doi:10.1007/978-88-470-5415-8_7
Hypertension in women
Taler, S. J. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0044-x

Authors: Woods, J. W.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Woods, J W
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1988-03
Volume: 11
Issue: 3_pt_2
Pages: II11-5
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.11.3_pt_2.ii11
OpenAlex: W1969269190
Cited by: 111
References: 21
Citations by year: 2026: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 5 · 2016: 1 · 2015: 6 · 2014: 3 · 2013: 3 · 2012: 2
FWCI: 1.66
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords: oral contraceptives, elevated blood pressure, estrogen, progestogens, cardiovascular risk, smoking, women over 35, contraceptive safety
MeSH terms: Animals, Cardiovascular Diseases, Contraceptives, Oral, Hormonal, Estrogens, Female, Humans, Hypertension, Progestins, Risk Factors, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oral contraceptives and hypertension.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks